New research shows that psilocybin can be more effective and less expensive than conventional drug therapies for severe depression. Read More
Analyst Articles
The rally’s momentum has stalled so far in August. Are we witnessing a healthy consolidation, or does a full-fledged correction await? Read More
The Federal Reserve’s hawkish minutes and grim economic news from China are pressuring equity markets in the U.S. and globally. Read More
Investing Daily’s editorial director interviews our top in-house expert on how to reliably boost income in up or down markets. Read More
The German government approved legislation this week that would allow adults to buy and possess recreational cannabis. The stakes are huge. Read More
New data point to s recovery in the crucial housing market, which bodes well for the American “wealth effect" and the overall stock market. Read More
The picture for the American economy is getting brighter, whereas China's economy is getting bleaker. We piece together the global context. Read More
It may be the dog days of August, but legal, regulatory, and political trends that affect the worldwide cannabis sector continue apace. Read More
After the robust rise in stocks so far this year, investors are digesting gains and reassessing prospects for the rest of 2023. Read More
The producer price index for July came in higher than consensus estimates. Is the setback temporary or a sign that inflation will resurface? Read More